Skip to main content
Equibles

FMR LLC

Position in BTAIQ — BioXcel Therapeutics, Inc.

CIK 315066 BOSTON, MA
Back to BTAIQ Full portfolio

Position in BTAIQ

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$127,323
+$6,321 QoQ
Shares Held
90,300
0.0% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 47 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BTAIQ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

FMR LLC holds $7,214,215,829 across 49 Drug Manufacturers - Specialty & Generic names. BTAIQ ranks #37 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VTRS
Viatris Inc
 96,662,102 $1,534,994,177
2 ELAN
Elanco Animal Health Inc
 56,948,819 $1,401,510,433
3 HLN
Haleon plc
 120,991,250 $1,128,848,360
4 TEVA
Teva Pharmaceutical Industries Ltd
 30,258,016 $1,025,141,579
5 KNSA
Kiniksa Pharmaceuticals International, plc
 6,971,361 $445,818,534
6 LNTH
Lantheus Holdings, Inc.
 3,879,971 $430,443,982
7 AMLX
Amylyx Pharmaceuticals, Inc.
 16,727,909 $300,433,243
8 UTHR
UNITED THERAPEUTICS Corp
 473,409 $256,507,196

All Filings in BTAIQ

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $127,323 90,300
2026-03-31 $121,002 90,300
2025-12-31 $144,480 90,300
2025-09-30 $508,416 198,600
2025-03-31 $22 11
2024-06-30 — 2,205,172
2024-03-31 — 2,494,116
2023-12-31 — 2,518,564
2023-09-30 — 2,700,727
2023-06-30 — 4,373,447
2023-03-31 — 4,276,693
2022-12-31 — 4,203,436
2022-09-30 — 4,197,625
2022-06-30 — 4,197,356
2022-03-31 — 4,197,324
2021-12-31 — 4,197,049
2021-09-30 — 3,785,384
2021-06-30 — 3,114,813
2021-03-31 — 2,229,843
2020-12-31 — 2,001,988
2020-09-30 — 1,926,620
2020-06-30 — 167,290
2020-03-31 — 605,490